ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Mississippi » Ophthalmology

Top Ophthalmology Prescribers in Mississippi

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHAEL COLEMAN M.D.

Ophthalmology

6,602

$483K

1363
1178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 58%

$73
Average prescription price

Avg: $66

LLOYD SMITH M.D.

Ophthalmology

5,432

$309K

846
765 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 58%

$57
Average prescription price

Avg: $66

MAURICE JAMES M.D.

Ophthalmology

4,368

$263K

783
642 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 58%

$60
Average prescription price

Avg: $66

JAMES BENNETT M.D.

Ophthalmology

3,889

$281K

762
661 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 58%

$72
Average prescription price

Avg: $66

RANDY RICHARDSON MD

Ophthalmology

3,620

$264K

626
578 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

53%
prescriptions for brand name drugs

Avg: 58%

$73
Average prescription price

Avg: $66

KENT KEBERT MD

Ophthalmology

3,390

$223K

622
540 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 58%

$66
Average prescription price

Avg: $66

CHRISTOPHER HOGAN M.D.

Ophthalmology

3,321

$162K

753
637 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 58%

$49
Average prescription price

Avg: $66

KENNETH HAYLES M.D.

Ophthalmology

3,303

$147K

517
429 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

50%
prescriptions for brand name drugs

Avg: 58%

$44
Average prescription price

Avg: $66

LEE COLEMAN M.D.

Ophthalmology

3,151

$213K

722
552 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 58%

$68
Average prescription price

Avg: $66

AUBREY NICHOLS M.D.

Ophthalmology

3,150

$186K

492
399 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

19%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 58%

$59
Average prescription price

Avg: $66

PATRICK DUFFY MD

Ophthalmology

3,083

$194K

364
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 58%

$63
Average prescription price

Avg: $66

SCOTT BRADLEY M.D.

Ophthalmology

3,003

$181K

520
446 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

53%
prescriptions for brand name drugs

Avg: 58%

$60
Average prescription price

Avg: $66

WILLIAM ASHFORD M.D.

Ophthalmology

2,932

$177K

616
537 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 58%

$60
Average prescription price

Avg: $66

JAMES BRUCE MD

Ophthalmology

2,879

$263K

631
535 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

80%
prescriptions for brand name drugs

Avg: 58%

$91
Average prescription price

Avg: $66

JAMES BROWN M. D.

Ophthalmology

2,814

$215K

517
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

74%
prescriptions for brand name drugs

Avg: 58%

$76
Average prescription price

Avg: $66

JEFFREY COOK M.D.

Ophthalmology

2,798

$170K

439
354 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

18%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 58%

$61
Average prescription price

Avg: $66

JAIME JIMENEZ AGOSTO M.D.

Ophthalmology

2,765

$126K

567
443 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 58%

$45
Average prescription price

Avg: $66

CHARLES RICHARDSON M.D.

Ophthalmology

2,730

$166K

635
557 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 58%

$61
Average prescription price

Avg: $66

DARWIN WOOTEN M.D.

Ophthalmology

2,684

$131K

576
475 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 58%

$49
Average prescription price

Avg: $66

THOMAS TANN MD

Ophthalmology

2,604

$155K

685
589 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 2%

19%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

62%
prescriptions for brand name drugs

Avg: 58%

$60
Average prescription price

Avg: $66

WILLIAM BRAWNER M.D.

Ophthalmology

2,538

$141K

505
449 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 58%

$55
Average prescription price

Avg: $66

JUDITH BRADLEY M.D.

Ophthalmology

2,522

$160K

535
414 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 58%

$64
Average prescription price

Avg: $66

MATTHEW WESSON M.D.

Ophthalmology

2,492

$190K

652
545 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

68%
prescriptions for brand name drugs

Avg: 58%

$76
Average prescription price

Avg: $66

JULIE LYNN MD

Ophthalmology

2,447

$179K

624
501 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 58%

$73
Average prescription price

Avg: $66

STONEY WILLIAMSON M.D.

Ophthalmology

2,414

$162K

633
566 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 58%

$67
Average prescription price

Avg: $66

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank